ANDERA PARTNERS

PARIS, I0 · CIK 1757283 · 13F filing filed 2026-07-22

Exempt reporting adviser since 2026 · other (specify)

Private funds11 · $4.3bn gross assets
Websiteanderapartners.com
Form ADV · 2026-09-15SEC adviser record

Legal entityANDERA PARTNERS (FR)

$206.5m reported value +16.7% vs Q1 2026

8positions

100.0%in top 10

1 new 2 added 1 reduced 0 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change	Shares change
1	KESTRA MED TECHNOLOGIES LTD SHS KMTS	KMTS	2,728,679	$69.4m33.62%	33.62%	Added +33.5k	+33,487 1.2%
2	MINERALYS THERAPEUTICS INC COM MLYS	MLYS	1,591,917	$42.9m20.80%	20.80%	Unchanged
3	AVALYN PHARMACEUTICALS INC COM SHS AVLN	AVLN	929,824	$30.6m14.82%	14.82%	New
4	AGOMAB THERAPEUTICS NV SPONSORED ADS AGMB	AGMB	1,538,702	$20.0m9.67%	9.67%	Unchanged
5	EVOMMUNE INC COM SHS EVMN	EVMN	1,391,990	$18.5m8.96%	8.96%	Reduced -505.4k	-505,372 -26.6%
6	INVENTIVA SA ADS IVA	IVA	3,633,181	$13.7m6.65%	6.65%	Added +1.8m	+1,815,000 99.8%
7	ABIVAX SA SPONSORED ADS ABVX	ABVX	78,125	$10.4m5.04%	5.04%	Unchanged
8	NYXOAH S A SHS NYXH	NYXH	522,057	$882.3k0.43%	0.43%	Unchanged

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

Company	Ticker	Stake	Change	Schedule	Last filed
INVENTIVA SA IVA · 13G · filed 2026-10-27	IVA	6.7%	-1.0 pts	13G	2026-10-27